Back to Search
JENNIFER JETT, MD
MD
Hospice and Palliative Medicine (Internal Medicine) Physician
NPI: 1770046617IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine Physician
Family Medicine
Code: 207Q00000X
13248644-1205(UT)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Hospice and Palliative Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Hospice and Palliative Medicine
Code: 207RH0002X
13248644-1205(UT)
CMS Specialties
PrimaryHOSPICE/PALLIATIVE CARE
Education
OTHER
Class of 2019
Research & Publications (20)
Change in smoking status after low-dose spiral chest CT screening for lung cancer: opportunity for smoking intervention.
PMID 19401483·Thorax·2009
8-other
5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size.
PMID 19581354·Chest·2009
8-other
Road ahead to respiratory health: experts chart future research directions.
PMID 19207117·Respirology·2009
6-review
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
PMID 19402175·Cancer·2009
8-other
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.
PMID 19349543·J Clin Oncol·2009
3-trial
18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
PMID 19527361·J Med Imaging Radiat Oncol·2009
6-review
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
PMID 19632941·Clin Lung Cancer·2009
8-other
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
PMID 19347979·J Thorac Oncol·2009
2-rct
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
PMID 18045731·Lung Cancer·2008
3-trial
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.
PMID 18827620·J Thorac Oncol·2008
8-other
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.
PMID 18050362·Psychooncology·2008
8-other
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
PMID 18378568·J Clin Oncol·2008
3-trial
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
PMID 18978555·J Thorac Oncol·2008
8-other
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
PMID 18674476·Mayo Clin Proc·2008
8-other
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).
PMID 17873173·Chest·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 9500 Euclid Ave # Na-23
Cleveland, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1770046617
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile